Tengion
Clinical-stage biotechnology company developing neo-organs and neo-tissues.
Market cap
$36.2k
Enterprise value
$36k
Share price
€0.00 TNGNQ
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor | €0.0 | round |
| investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | N/A | Bankruptcy |
| Total Funding | 000k | ||
Celgene(exited)
Oak Investment(exited)
L Capital Partners(exited)
HealthCap(exited)
Bain Capital(exited)
Deerfield Partners(exited)
Safeguard Scientifics(exited)
J&J Development(exited)
Deerfield Capital Management(exited)
Oxford Finance(exited)
Quaker Bio Ventures(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.